Learn more →
Back to Expert Scholars
clinical-trials / clinical-trialsPhase I/II Clinical Trials

Udai Banerji

乌代·班纳吉

MBBS, PhD, FRCP

🏢Institute of Cancer Research / Royal Marsden Hospital(癌症研究所/皇家马斯登医院)🌐UK

Professor of Molecular Cancer Pharmacology; Head of Drug Development分子癌症药理学教授;药物开发部主任

58
h-index
2
Key Papers
3
Awards
3
Key Contributions

👥Biography 个人简介

Udai Banerji is a leader in pharmacodynamic biomarker development for early-phase oncology trials. He has pioneered the use of paired tumor biopsies and functional imaging to demonstrate target engagement, dose optimization, and mechanism of action for novel agents in first-in-human studies.

Share:

🧪Research Fields 研究领域

Clinical Trials临床试验
Pharmacodynamic Biomarkers药效学生物标志物
HSP90 InhibitorsHSP90抑制剂
Early Drug Development早期药物开发

🎓Key Contributions 主要贡献

Pharmacodynamic Biomarker Methodology

Established serial tumor biopsy and functional imaging frameworks for early-phase trials, enabling proof-of-mechanism studies that inform dose selection and combination strategies.

HSP90 Inhibitor Development

Led clinical development of multiple HSP90 inhibitors, including ganetespib and luminespib, defining pharmacodynamic endpoints that guided oncology drug development decisions.

PI3K/AKT Early Trial Expertise

Conducted pivotal early-phase trials of AKT inhibitors (capivasertib, ipatasertib), informing combination strategies with endocrine therapy and chemotherapy.

Representative Works 代表性著作

[1]

Pharmacodynamic Biomarker Study of the HSP90 Inhibitor 17-AAG in Solid Tumors

Journal of Clinical Oncology (2005)

Landmark early-phase pharmacodynamic study demonstrating HSP90 target engagement through serial tumor biopsies.

[2]

Phase I Trial of Capivasertib (AZD5363) in Advanced Solid Tumors

Cancer Discovery (2017)

Defined dose, PK, safety, and pharmacodynamic biomarkers for AKT inhibitor capivasertib, underpinning subsequent phase III development.

🏆Awards & Recognition 奖项与荣誉

🏆ICR Research Excellence Award
🏆ECMC Network Investigator of the Year
🏆AACR-ASCO Methods in Clinical Cancer Research Award

📄Data Sources 数据来源

Last updated: 2026-01-15 | All information from publicly available academic sources

关注 乌代·班纳吉 的研究动态

Follow Udai Banerji's research updates

留下邮箱,当我们发布与 Udai Banerji(Institute of Cancer Research / Royal Marsden Hospital)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment